The increasing incidence of Alzheimer's disease (AD) and related sleep-disorders with the aging of the population is a major issue of public health. The prevalence of sleep disturbances is about 50% in dementia patients. Sleep in dementia is mainly characterized by prolonged night-time awakenings, sometimes with longer sleep latency and/or early awakening. The presence of these sleep disturbances is the main reason for the institutionalization of AD patients, as well as a major cause of the deterioration of the caregivers' sleep. The MEMENTO cohort is composed of patients with isolated memory complaints or mild cognitive impairment, at high risk to develop dementia. All voluntary patients from the CMRR (Center of Memory, resources and Research) of Bordeaux (MEMENTO cohort) will be tested at inclusion and followed-up 1 year later. For these two evaluations, actigraphic monitoring at home, 2-night polysomnography (PSG) monitoring at hospital including a 24-hour period of urinary melatonin dosage, neuropsychological tests battery, a virtual reality tool and questionnaires will be used.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
58
Polysomnography
CHU de Bordeaux
Bordeaux, France
Polysomnography of night 1
\- Apnea/Hypopnea index, periodic limb movements index
Time frame: Change from inclusion (Month 0) and Month 12
Polysomnography of night 1
\- Excessive transient muscle activity, Sustained muscle activity
Time frame: Change from inclusion (Month 0) and Month 12
Polysomnography of night 1
\- Sleep structure parameters (% stage 1, 2, 3 and Rapid Eye movement, Delta activity, Spindle rate)
Time frame: Change from inclusion (Month 0) and Month 12
Polysomnography of night 1
\- Sleep duration parameters
Time frame: Change from inclusion (Month 0) and Month 12
Polysomnography of night 1
\- Sleep consolidation parameters
Time frame: Change from inclusion (Month 0) and Month 12
Polysomnography of night 1
\- Sleep propensity parameters 24-hour melatonin quantity rate
Time frame: Change from inclusion (Month 0) and Month 12
Polysomnography of night 1
Actimetry: Inter-daily stability, intra-daily variability, rhythm amplitude
Time frame: Change from inclusion (Month 0) and Month 12
Subjective evaluation of sleep and Somnolence
Time frame: Month 0 and Month 12
Evaluation of Memory disorder
Reaction times and % of errors in the neuropsychological tests (memory, speed processing, language, visuo-spatial skills, attentional functions, executive functions)
Time frame: Month 0 and Month12
Evaluation of Memory disorder
% of recall from the memory test in a virtual environment
Time frame: Month 0 and Month12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.